Description
In this presentation, BB Handley highlights the importance of monitoring patient outcomes in orthopedic trauma, referencing a lack of routine data collection in the field, particularly beyond hip fracture survival rates. He discusses the implementation of a new initiative called MDOR (Musculoskeletal Device Outcome Registry) which will facilitate better tracking of treatments and outcomes, emphasizing the need for clinical input in its development. Handley highlights the necessity of traceability for implants used in surgeries, proposing that all implants, including screws, must be adequately documented and tracked. He raises several clinical questions regarding the implications of removing implants and emphasizes the need for reliable mechanisms to trace implants that are removed from patients, particularly in trauma cases.
The importance of a clinical steering group is underscored, with Handley encouraging the community's involvement in shaping the future of such registries to ensure they meet the needs of the field. He mentions the value of coding systems like the AO classification for standardizing diagnoses and treatment approaches. Handley expresses optimism about the potential of the MDOR to aid in clinical trials and the overall improvement of patient outcomes through real-time data reporting and collaboration with existing medical databases.
The takeaway message is a strong call for orthopedic trauma clinicians to seize the opportunity to actively participate in data collection, analysis, and improvement of practices to ensure meaningful changes in patient care.